更なる成長の黎明期、上抜け圏にて、強気相場解除後の時間軸での調整は順調推移。笑。 時間軸調整にて、信用組の振るいも順調に推移し、今回も調整終盤の拾い場を経て、予定通りに面白くなりましたね。笑。 中長期の成長戦略も着実に進み、次なる展開・進捗が楽しみですね。笑。 0727山師さん@トレード中 (アウアウウー Sac3-RYL0)2017/12/17(日) 08:09:45.01ID:SaP7o1GTa ヘンダーソン博士の講演会行きたい奴は現物買っとけよ 0728山師さん@トレード中 (ワッチョイWW c66c-Ebcr)2017/12/17(日) 09:25:05.58ID:q0nHhjM+0 いらねえよ どうせわかってもいないのに、わかったつもりの受け売りの知識で行った感想書き込まれるんだな 0729山師さん@トレード中 (ワッチョイ 0281-j1NZ)2017/12/17(日) 09:58:21.92ID:mTfygXFF0 来年から12月期決算になるはずなのに四季報に反映されていない 0730山師さん@トレード中 (ワッチョイ 9797-iaxY)2017/12/17(日) 17:52:28.47ID:Nz1KtFm40 そーせいスレ最終回でございます 次の大相場までごきげんよう 0731山師さん@トレード中 (ワッチョイ 538e-od5V)2017/12/17(日) 18:01:05.00ID:31eJg76w0 Pluristem: ※Pluristem: Pluristem and Sosei CVC to Establish a New Corporation for the Commercialization of PLX-PAD in Japan. (2016/12/20) ※Pluristem: Pluristem’s Phase III Study of PLX-PAD Cells for the Treatment of Critical Limb Ischemia Cleared by U.S. FDA. (1/10) ※Pluristem: Receives Clearance from Germany to Initiate its Multinational Phase III Trial in Critical Limb Ischemia Targeting Early Conditional Marketing Approval. (1/17) ※Pluristem: Pluristem and Sosei CVC Advancing Towards Finalizing Joint Venture forthe Commercialization of PLX-PAD in Japan. (3/30) ※Pluristem Presentation: "Closing JV deal with Sosei: H2 2017", "Japan pivotal study initiation: H1 2018" (Change, 9/17up) (・"Extend the deadline to enter into a definitive agreement by 2017/12/31" SoseiCVC Agreed 8/15. As a next step, submit a Clinical Trial notification to the PMDA.) ※Pluristem: U.S. FDA Grants Fast Track Designation to PLX-PAD for the Treatment of CLI. (In Japan, accepted accelerated regulatory pathway.) (9/18) ※Pluristem: Presentation October: ttp://www.pluristem.com/wp-content/uploads/2016/04/Pluristem-Investor-deck-29.10.2017.pdf (10/29up) (・Pluristem: Video- Japanese: ttps://www.youtube.com/watch?v=kw_JP6FixMI (2015/02/10up)) (・Pluristem: Stem Cell Meeting on the Mesa 2015: ttps://www.youtube.com/watch?v=ON82ZQa-pfg (2015/10/22up)) (・Pluristem: Advanced Therapies Investor Day: ttps://www.youtube.com/watch?v=bVOOuyLvBbM&t (2015/11/30up)) (・Pluristem: Cell Gene Meeting on the Mesa 2016: ttps://www.youtube.com/watch?v=wMN4SoVpPSw (2016/10/24up)) (・Pluristem: Cell Gene Investor Day: ttps://www.youtube.com/watch?v=BlsEDBrOEbw (5/4up)) (・Pluristem: PLX-PAD Instructions, Study PLX-CLI-03(NCT03006770): ttps://www.youtube.com/watch?v=h_t3oDhEkIg&t (5/14up)) (・Pluristem: Zami Aberman - NHPs Study Results for ARS: ttps://www.youtube.com/watch?v=i4nRUESNAXk (5/18up)) (・Pluristem: Placental Cell Therapy: ttps://www.youtube.com/watch?v=1A3zI68uWFY (6/15up)) (・Pluristem: Cell Therapy – The Next Generation of Biological Therapeutic Products: ttps://www.youtube.com/watch?v=DXrqyLm-YwM (6/24up)) (・Pluristem: PLX-PAD as a Treatment for Peripheral Artery Disease- CLI - Unmet Needs: ttps://www.youtube.com/watch?v=niOhN-fEQmU&t (6/27up)) (・Pluristem: The Solution for Nuclear Disaster: ttps://www.youtube.com/watch?v=larWZ1dRxMA (7/20up)) (・Pluristem: Cell Therapy- The Answer for Aging and Longevity: ttps://www.youtube.com/watch?v=scxgz3BOITE (7/20up)) (・Pluristem: Cell Therapy to treat Acute Radiation Syndrome: ttps://www.youtube.com/watch?v=jyD-oXHUwqQ&t (8/27up)) (・Pluristem: US Military Testing Radiation Exposure Drug- CNN: ttps://www.youtube.com/watch?v=N1jjf5s7iHY (9/2up)) (・Pluristem: Introduction with Pluristem: ttps://www.youtube.com/watch?v=q79hgJQgRps (10/4up)) (・Pluristem: Instructions For IP Use in Clinical Trial PLX-PAD 1204-01(NCT01679990): ttps://www.youtube.com/watch?v=1kMtv1mU8n0 (11/2up)) ※Pluristem: Innovative Technology, Cell Therapy Products and a Potentially Answer for Radiation Exposure: ttps://www.youtube.com/watch?v=yqLDlikcG_I (11/23up) ※Pluristem: Peer-Reviewed Article Published on PLX-PAD Cells’ Mechanism of Action to Restore Blood Flow in Ischemic Tissue. "Data Supports Advanced PLX-PAD Clinical." (11/29) ※Pluristem: The Jerusalem Post Diplomatic Conference: Presents at Cure for Radiation Catastrophes. ttps://www.youtube.com/watch?v=ZiEj_pnmc38 (12/6) ※Pluristem: Granted Manufacturer Authorization and GMP Certification by Israel’s Ministry of Health. "The Approval Supports the Readiness of Manufacturing Capabilities." (12/12) ・・・